
12 years ago
Alum News
Updates from our department alum

12 years ago
Updates from our department alum

12 years ago
Jon successfully defended his dissertation and received his PhD on July 1, 2014.

12 years ago
We welcome Dr. Silvia Ramos who has just joined the lab of Dr. Bill Marzluff as a new research faculty member in the Department.

12 years ago
Congratulations to Dr. Dileep Varma on his new tenure-track faculty position with the Department of Cell and Molecular Biology at Northwestern University Feinberg School of Medicine in Chicago.

12 years ago
Congratulatons to Dr. Shobhan Gaddameedhi on his new Assistant Professor position with the Department of Experimental and Systems Pharmacology at Washington State University.

12 years ago
Drs. Brian Strahl, Professor of Biochemistry and Biophysics at UNC-Chapel Hill along with Or Gozani, Associate Professor at Stanford, and Mark Bedford, Professor of Molecular Carcinogenesis at the University of Texas are the scientific founders of EpiCypher, a company that develops and manufactures novel products and tools for epigenetics and chromatin biology research. As of earlier this month, the operations have been moved from Texas to UNC-Chapel Hill campus.

12 years ago
Ivan successfully defended his dissertation and received his PhD on June 23, 2014.

12 years ago
In the June 19, 2014 edition of Molecular Cell, the Dohlman lab publishes a paper "Cellular Noise Suppression by the Regulator of G Protein Signaling Sst2."

12 years ago
Congrats to Joseph Pearson for publishing a first author paper in Developmental Biology. His article "Enhancer diversity and the control of a simple pattern of Drosophila CNS midline cell expression" was available online ahead of print on May 20, 2014.

12 years ago
Congratulations to Dr. Brian Strahl, Professor of Biochemistry and Biophysics for receiving grants from the NIH and NSF

12 years ago
Learn more about our new entering class of students and help us welcome them to the department.

12 years ago
The discovery, from the lab of Brian Strahl, PhD, offers insights for the creation of better, more targeted therapies for various forms of cancer.